临床试验

AERO CAD Study Evaluating the Shockwave C2 Aero IVL System in Coronary Artery Disease

NCT：NCT07512206 · NOT_YET_RECRUITING

NCT编号NCT07512206

状态NOT_YET_RECRUITING

开始日期2026-04-01

完成时间2026-12-01

简要摘要

The AERO CAD study is a prospective, multi-center, single-arm, post-market clinical investigation evaluating the procedural performance and clinical outcomes of the Shockwave C2 Aero Coronary Intravascular Lithotripsy (IVL) System in patients with calcified coronary artery disease undergoing percutaneous coronary intervention (PCI). The study will enroll up to 200 subjects across up to 8 U.S. sites. The primary objective is to generate real-world evidence on device performance and clinical outcomes, including target lesion failure at 30 days and procedural success.

官方来源

在 ClinicalTrials.gov 上查看 →

数据来自 ClinicalTrials.gov API。有关最新状态，请参阅官方记录。